|

Ozone therapy Clinical Trials

2 actively recruiting trials

Also known as: O3, O3/O2 gas mixture, Ozone treatment

Pipeline

Phase 2/3: 2

Top Sponsors

  • Bernardino Clavo, MD, PhD2

Indications

  • Tingling2
  • Numbness2
  • Paresthesia2
  • Chemotherapy Induced Peripheral Neuropathy (CIPN)2
  • Depression2

Other2 trials

Gut Microbiome Profiles in Patients with Chemotherapy-induced Neuropathy in the RCT OzoParQT (NCT06706544).
Phase 2/3
Ozone Treatment in Paresthesia (Numbness, Tingling) Secondary to Chemotherapy-induced Peripheral Neuropathy
Phase 2/3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.